Inside Precision Medicine May 15, 2024
Laura Cowen

The Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has announced the establishment of the Sylvester Brain Tumor Institute (SBTI), which will focus on personalized medicine approaches for treating patients with brain tumors.

“The institute will allow us to have a critical mass of clinicians, surgeons, translational scientists and basic scientists working together toward a goal of generating treatments that are tailored to each individual patient at Sylvester,” said the new institute director Antonio Iavarone. “This is a complex and ambitious goal. You need multiple people with complementary expertise working together—this is what has driven the creation of the SBTI.”

Anna Lasorella, co-director of basic and translational research at the SBTI told Inside Precision Medicine...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Pharma / Biotech, Precision Medicine, Provider
Innovations in Preventive Care – Staying Ahead of Health Issues
Foresite Capital Closes $900M Fund Targeting Precision Medicine & Innovation
UK Biobank Pivoting to Platform-Only Model For Big Data Sharing
Precision medicine for sepsis in children within reach
GE Healthcare Unveils Solutions to Expand Access to Precision Medicine

Share This Article